These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3443056)

  • 1. Is hypertension treated adequately?
    Hansson L; Robertson JI
    Drugs; 1987; 34 Suppl 3():1-6. PubMed ID: 3443056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What are we really achieving with long-term drug therapy?
    Hansson L
    Am J Hypertens; 1988 Oct; 1(4 Pt 1):414-20. PubMed ID: 3063292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of pharmacological therapy for risk factor reduction. Hypertension.
    Hansson L
    Drugs; 1988; 36 Suppl 3():110-4. PubMed ID: 3076114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiences from hypertension trials. Impact of other risk factors.
    Samuelsson O
    Drugs; 1988; 36 Suppl 3():9-20. PubMed ID: 3076127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and future strategies in the treatment of hypertension.
    Hansson L
    Am J Cardiol; 1988 Feb; 61(5):2C-7C. PubMed ID: 3341223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk factors and their interactions in hypertensives.
    Lindholm LH
    J Hypertens Suppl; 1991 Dec; 9(3):S3-6. PubMed ID: 1797997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
    Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H
    Am J Hypertens; 1997 Jul; 10(7 Pt 1):705-13. PubMed ID: 9234823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of increased left ventricular mass despite optimal blood pressure control in hypertension.
    Schillaci G; Verdecchia P; de Simone G; Sacchi N; Bruni B; Benemio G; Porcellati C
    Ital Heart J; 2000 May; 1(5):354-60. PubMed ID: 10832812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive therapy: new strategies beyond blood pressure control.
    Stumpe KO
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S1-4. PubMed ID: 1283182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aims of treatment of hypertension.
    Hansson L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S51-4; discussion S55. PubMed ID: 2481170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General considerations when treating hypertension.
    Hansson L
    Drugs; 1993; 46 Suppl 2():37-9. PubMed ID: 7512480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertension as a function of age].
    Gensini GF; Corradi F
    Ital Heart J; 2000 Jun; 1 Suppl 2():23-31. PubMed ID: 10905125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of antihypertensive drugs on the cardiovascular patient.
    Hansson L
    Am Heart J; 1987 Jul; 114(1 Pt 2):221-3. PubMed ID: 3300234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drugs and arterial stiffness in hypertensive patients].
    Laurent S
    Drugs; 2003; 63 Spec No 1():1-8. PubMed ID: 12708878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.